Sophion Therapeutics, based in New Haven, is a pioneering biotech company focused on developing cutting-edge monoclonal and bispecific antibodies.
Their innovative approach targets devastating diseases with unmet medical needs, providing hope for improved treatments where current options fall short.
Generated from their website's infomation